English

GEOVAX LABS, INC.

EDGAR

GOVX Current report (8-K) · filed 2026-10-27

174 filing records in this dataset, filed from 1996-08-13 to 2026-10-27. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 3.14 million USD 2026-06-30 Source
Exact value

3143422 USD
Long-term debt including current maturities: Not available
Shares outstanding: 7.37 million shares 2026-06-30 Source
Exact value

7369243 shares

Reported share-count change

-53.72% · -8.56 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

15924593 shares · 2025-06-30· Source
7369243 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 3.53 million

Prior period

−USD 24.99 million

2024-01-01 – 2024-12-31
Current period

−USD 21.46 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-21464771 − -24992296 = 3527525 USD

-24992296 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-21464771 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Year-over-year change in Net income: 3527525 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -21464771 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#754363 Filing: 000143774926012377 Input fundies:NetIncome: -24992296 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#755060 Filing: 000143774926012377
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.2 million

Prior period

−USD 24.68 million

2024-01-01 – 2024-12-31
Current period

−USD 21.47 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-21473969 − -24675511 = 3201542 USD

-24675511 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-21473969 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Year-over-year change in Operating cash flow: 3201542 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -21473969 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#771999 Filing: 000143774926012377 Input fundies:OperatingCashFlow: -24675511 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#772712 Filing: 000143774926012377
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+33.7%

Prior period

USD 20,653

2024-01-01 – 2024-12-31
Current period

USD 27,612

2025-01-01 – 2025-12-31

Exact inputs and evidence

27612 − 20653 = 6959 USD

20653 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
27612 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Year-over-year change in Capital expenditure: 6959 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 27612 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#776219 Filing: 000143774926012377 Input fundies:CapitalExpenditure: 20653 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#777039 Filing: 000143774926012377
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 2.37 million Exact value Exact value: -2370629 USD 2019-01-01 – 2019-12-31: -2370629 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2019-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -2370629 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2370629 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922002516/govx-20210930.htm#1523893 Filing: 000143774922002516 The citation records this snapshot. The page link may show a newer release later.	−USD 1.4 million Exact value Exact value: -1398497 USD 2019-01-01 – 2019-12-31: -1398497 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2019-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -1398497 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1398497 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922002516/govx-20210930.htm#1538403 Filing: 000143774922002516 The citation records this snapshot. The page link may show a newer release later.	USD 7,606 Exact value Exact value: 7606 USD 2019-01-01 – 2019-12-31: 7606 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2019-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 7606 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7606 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922002516/govx-20210930.htm#1541503 Filing: 000143774922002516 The citation records this snapshot. The page link may show a newer release later.	−USD 1.41 million Calculation and evidence -1398497 − 7606 USD Exact free cash flow: -1406103 USD 2019-01-01 – 2019-12-31: -1398497 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 7606 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2019-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -1406103 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1398497 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922002516/govx-20210930.htm#1538403 Filing: 000143774922002516 Input fundies:CapitalExpenditure: 7606 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922002516/govx-20210930.htm#1541503 Filing: 000143774922002516 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 2.96 million Exact value Exact value: -2958068 USD 2020-01-01 – 2020-12-31: -2958068 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2020-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -2958068 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2958068 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922014947/govx-20220331.htm#1303633 Filing: 000143774922014947 The citation records this snapshot. The page link may show a newer release later.	−USD 2.75 million Exact value Exact value: -2750570 USD 2020-01-01 – 2020-12-31: -2750570 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2020-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -2750570 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2750570 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922014947/govx-20220331.htm#1322276 Filing: 000143774922014947 The citation records this snapshot. The page link may show a newer release later.	USD 156,791 Exact value Exact value: 156791 USD 2020-01-01 – 2020-12-31: 156791 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2020-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 156791 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 156791 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922014947/govx-20220331.htm#1325408 Filing: 000143774922014947 The citation records this snapshot. The page link may show a newer release later.	−USD 2.91 million Calculation and evidence -2750570 − 156791 USD Exact free cash flow: -2907361 USD 2020-01-01 – 2020-12-31: -2750570 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 156791 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2020-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -2907361 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2750570 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922014947/govx-20220331.htm#1322276 Filing: 000143774922014947 Input fundies:CapitalExpenditure: 156791 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774922014947/govx-20220331.htm#1325408 Filing: 000143774922014947 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 18.57 million Exact value Exact value: -18570317 USD 2021-01-01 – 2021-12-31: -18570317 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2021-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -18570317 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18570317 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924000191/govx20231222_s1.htm#1234721 Filing: 000143774924000191 The citation records this snapshot. The page link may show a newer release later.	−USD 11.2 million Exact value Exact value: -11196420 USD 2021-01-01 – 2021-12-31: -11196420 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2021-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -11196420 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11196420 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924000191/govx20231222_s1.htm#1254299 Filing: 000143774924000191 The citation records this snapshot. The page link may show a newer release later.	USD 47,718 Exact value Exact value: 47718 USD 2021-01-01 – 2021-12-31: 47718 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2021-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 47718 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 47718 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924000191/govx20231222_s1.htm#1257601 Filing: 000143774924000191 The citation records this snapshot. The page link may show a newer release later.	−USD 11.24 million Calculation and evidence -11196420 − 47718 USD Exact free cash flow: -11244138 USD 2021-01-01 – 2021-12-31: -11196420 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 47718 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2021-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -11244138 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11196420 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924000191/govx20231222_s1.htm#1254299 Filing: 000143774924000191 Input fundies:CapitalExpenditure: 47718 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924000191/govx20231222_s1.htm#1257601 Filing: 000143774924000191 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 14.02 million Exact value Exact value: -14021125 USD 2022-01-01 – 2022-12-31: -14021125 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2022-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -14021125 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14021125 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924028643/govx20240904c_s1.htm#1460731 Filing: 000143774924028643 The citation records this snapshot. The page link may show a newer release later.	−USD 19.03 million Exact value Exact value: -19030208 USD 2022-01-01 – 2022-12-31: -19030208 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2022-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -19030208 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19030208 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924028643/govx20240904c_s1.htm#1478435 Filing: 000143774924028643 The citation records this snapshot. The page link may show a newer release later.	USD 134,258 Exact value Exact value: 134258 USD 2022-01-01 – 2022-12-31: 134258 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2022-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 134258 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 134258 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924028643/govx20240904c_s1.htm#1482822 Filing: 000143774924028643 The citation records this snapshot. The page link may show a newer release later.	−USD 19.16 million Calculation and evidence -19030208 − 134258 USD Exact free cash flow: -19164466 USD 2022-01-01 – 2022-12-31: -19030208 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 134258 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2022-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -19164466 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19030208 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924028643/govx20240904c_s1.htm#1478435 Filing: 000143774924028643 Input fundies:CapitalExpenditure: 134258 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774924028643/govx20240904c_s1.htm#1482822 Filing: 000143774924028643 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 25.97 million Exact value Exact value: -25966762 USD 2023-01-01 – 2023-12-31: -25966762 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2023-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -25966762 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25966762 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774925020507/govx20250612_s1.htm#1108387 Filing: 000143774925020507 The citation records this snapshot. The page link may show a newer release later.	−USD 25.17 million Exact value Exact value: -25173639 USD 2023-01-01 – 2023-12-31: -25173639 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2023-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -25173639 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25173639 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774925020507/govx20250612_s1.htm#1126025 Filing: 000143774925020507 The citation records this snapshot. The page link may show a newer release later.	USD 48,946 Exact value Exact value: 48946 USD 2023-01-01 – 2023-12-31: 48946 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2023-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 48946 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48946 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774925020507/govx20250612_s1.htm#1130352 Filing: 000143774925020507 The citation records this snapshot. The page link may show a newer release later.	−USD 25.22 million Calculation and evidence -25173639 − 48946 USD Exact free cash flow: -25222585 USD 2023-01-01 – 2023-12-31: -25173639 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 48946 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2023-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -25222585 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25173639 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774925020507/govx20250612_s1.htm#1126025 Filing: 000143774925020507 Input fundies:CapitalExpenditure: 48946 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774925020507/govx20250612_s1.htm#1130352 Filing: 000143774925020507 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 24.99 million Exact value Exact value: -24992296 USD 2024-01-01 – 2024-12-31: -24992296 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2024-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -24992296 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24992296 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#755060 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.	−USD 24.68 million Exact value Exact value: -24675511 USD 2024-01-01 – 2024-12-31: -24675511 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2024-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -24675511 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24675511 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#772712 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.	USD 20,653 Exact value Exact value: 20653 USD 2024-01-01 – 2024-12-31: 20653 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2024-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 20653 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20653 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#777039 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.	−USD 24.7 million Calculation and evidence -24675511 − 20653 USD Exact free cash flow: -24696164 USD 2024-01-01 – 2024-12-31: -24675511 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 20653 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2024-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -24696164 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24675511 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#772712 Filing: 000143774926012377 Input fundies:CapitalExpenditure: 20653 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#777039 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 21.46 million Exact value Exact value: -21464771 USD 2025-01-01 – 2025-12-31: -21464771 USD Inspect Net Income Open source Share or cite Citation for Net Income · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Net Income: -21464771 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21464771 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#754363 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.	−USD 21.47 million Exact value Exact value: -21473969 USD 2025-01-01 – 2025-12-31: -21473969 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Operating Cash Flow: -21473969 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21473969 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#771999 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.	USD 27,612 Exact value Exact value: 27612 USD 2025-01-01 – 2025-12-31: 27612 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Capital Expenditure: 27612 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27612 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#776219 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.	−USD 21.5 million Calculation and evidence -21473969 − 27612 USD Exact free cash flow: -21501581 USD 2025-01-01 – 2025-12-31: -21473969 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 27612 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GEOVAX LABS, INC. · 2025-12-31 GEOVAX LABS, INC. (edgar:832489) Free cash flow: -21501581 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/832489?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21473969 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#771999 Filing: 000143774926012377 Input fundies:CapitalExpenditure: 27612 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/832489/000143774926012377/govx20251231_10k.htm#776219 Filing: 000143774926012377 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

174 filings · 3,411 latest values · 3,411 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000832489, 832489, GOVX, edgar:832489, govx

Also known as DAUPHIN TECHNOLOGY INC, GEOVAX LABS, INC., GeoVax Labs, Inc., Geovax Labs, Inc.

GEOVAX LABS, INC.

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation